Walgreens Boots Alliance Inc
NASDAQ:WBA
Walgreens Boots Alliance Inc
NASDAQ:WBA
Price:
17.81 USD
1.6%
Market Closed
Updated:
May 6, 2024
P/E
Price to Earnings
Price to Earnings
-2.5
Current
5.5
Median
16.4
Industry
Lower
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=-2.5
Market Cap
/
15.4B
Net Income
-6B
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
15.4B USD | -2.5 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
72.8B Zac | 0 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
28.4B Zac | 0 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
45B BRL | 42.6 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
44.2B CNY | 30.7 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
927.9B JPY | 18.3 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.9B SAR | 20 | |
| MX |
|
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
77.1B MXN | 17.1 | |
| JP |
|
Cosmos Pharmaceutical Corp
TSE:3349
|
582.5B JPY | 24.2 | |
| JP |
|
Sundrug Co Ltd
TSE:9989
|
526.2B JPY | 18.7 | |
| CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
24.7B CNY | 19.2 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
5.5
2-Years Forward
P/E
5.7
3-Years Forward
P/E
5.1
You don't have any saved screeners yet
